chr16-27443104-C-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181078.3(IL21R):c.495C>A(p.Asp165Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000658 in 1,611,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_181078.3 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- cryptosporidiosis-chronic cholangitis-liver disease syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_181078.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IL21R | NM_181078.3 | MANE Select | c.495C>A | p.Asp165Glu | missense | Exon 5 of 9 | NP_851564.1 | ||
| IL21R | NM_181079.5 | c.561C>A | p.Asp187Glu | missense | Exon 6 of 10 | NP_851565.4 | |||
| IL21R | NM_021798.4 | c.495C>A | p.Asp165Glu | missense | Exon 5 of 9 | NP_068570.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IL21R | ENST00000337929.8 | TSL:1 MANE Select | c.495C>A | p.Asp165Glu | missense | Exon 5 of 9 | ENSP00000338010.3 | ||
| IL21R | ENST00000395754.4 | TSL:1 | c.495C>A | p.Asp165Glu | missense | Exon 5 of 9 | ENSP00000379103.4 | ||
| IL21R | ENST00000564089.5 | TSL:5 | c.495C>A | p.Asp165Glu | missense | Exon 6 of 10 | ENSP00000456707.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152096Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000523 AC: 13AN: 248372 AF XY: 0.0000671 show subpopulations
GnomAD4 exome AF: 0.0000672 AC: 98AN: 1459026Hom.: 0 Cov.: 31 AF XY: 0.0000689 AC XY: 50AN XY: 725744 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74410 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cryptosporidiosis-chronic cholangitis-liver disease syndrome Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 165 of the IL21R protein (p.Asp165Glu). This variant is present in population databases (rs779790998, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with IL21R-related conditions. ClinVar contains an entry for this variant (Variation ID: 540992). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Uncertain:1
The c.561C>A (p.D187E) alteration is located in exon 6 (coding exon 5) of the IL21R gene. This alteration results from a C to A substitution at nucleotide position 561, causing the aspartic acid (D) at amino acid position 187 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at